Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain

AIDS Research and Human Retroviruses

Volumn 14, Issue 5, 1998, Pages 453-459

  Debyser, Zeger ^a   Van Wijngaerden, Eric ^b   Van Laethem, Kristel ^a   Beuselinck, Kurt ^a   Reynders, Martin ^a   De Clercq, Erik ^a   Desmyter, Jan ^a   Vandamme, Anne Mieke ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC ERROR; DNA SEQUENCE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; PHYLOGENY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STRAIN DIFFERENCE; VIRUS LOAD; VIRUS TYPING;

EID: 0032549492     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.453     Document Type: Article

References (33)

1. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, and Volberding PA: HIV viral load markers in clinical practice. Nature Med 1996;2:625-629.
2. Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, and Gupta P: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573-579.
3. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, and Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
4. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-954.
5. Danner SA, Carr A, Leonard JM, Lehman LM, Gudiol F, GonzaIes J, Raventos A, Rubio R, Bouza E, Pintado V, et al.: A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N Engl J Med 1995;333: 1528-1533.
6. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
7. + lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Intern Med 1997;126:929-938.
8. + lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann Intern Med 1997;126:939-945.
9. Fang G, Burger H, Grimson R, Tropper P, Nachman S, Mayers D, Weislow O, Moore R, Reyelt C, Hutcheon N, Baker D, and Weiser B: Maternal plasma human immunodeficiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission. Proc Natl Acad Sci USA 1995;92:12100-12104.
10. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C, Song J-L, Jin Z, Zhao J-Q, Clapp S, Chen ISY, Ho DD, Ammann AJ, and the Ariel Project Investigators: Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nature Med 1997;3:549-552.
11. Revets H, Marissens D, De Wit S, Lacor P, Clumeck N, Lauwers S, and Zissis G: Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANTIPLEX HIV RNA assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:1058-1064.
12. Schuurman R, Descamps D, Weverling GJ, Kaye S, Tijnagel J, Williams I, van Leeuwen R, Tedder R, Boucher CAB, Brun-Vézinet F, and Loveday C: Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:3016-3022.
13. Vandamme A-M, Schmit J-C, Van Dooren S, Van Laethem K, Gobbers E, Kok W, Goubau P, Witvrouw M, Peetermans W, De Clercq E, and Desmyter J: Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the Amplicor HIV Monitor test. J AIDS Res Hum Retroviruses 1996;13: 127-139.
14. van Gemen B, Van Beuningen R, Nabbe A, van Strijp D, Jurriaans S, Lens P, and Kievits T: A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labeled probes. J Virol Methods 1994;49:157-168.
15. Kern D, Collins M, Fultz T, Detmer J, Hamren S, Peterkin J, Sheridan P, Urdea M, White R, Yeghiazarian T, and Todd J: An enhanced-sensitivity branched-DNA assay foe quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1996;34:3196-3202.
16. Vandamme A-M, Fransen K, Debaisieux L, Marissens D, Sprecher S, Vaira D, Vandenbroucke AT, and Verhofstede C: Standardization of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. J Virol Methods 1995;51:305-316.
17. Van Laethem K, Beuselinck K, Van Dooren S, De Clercq E, Desmyter J, and Vandamme A-M: Diagnosis of human immunodeficiency virus infection by a polymerase chain reaction assay evaluated in patients harbouring strains of diverse geographical origin. J Virol Methods 1998 (in press).
18. Felsenstein J: PHYLIP - Phylogeny inference package (version 3.2). Cladistics 1989;5:164-166.
19. Maddison WP and Maddison DR: MacClade, version 3: Analysis of Phylogeny and Character Evolution. Sinauer Associates, Sunderland, Massachusetts, 1992.
20. Felsenstein J: Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985;39:783-791.
21. Vanden Haesevelde M, Delcourt JL, De Leys R, Vanderborght B, van der Groen G, van Heuverswyn H, and Saman E: Genomic cloning and complete sequence analysis of a highly divergent African HIV isolate. J Virol 1994;68:1586-1596.
22. Alizon M, Sonigo P, Barré-Sinoussi F, Chermann JC, Tiollais P, Montagnier L, and Wain-Hobson S: Molecular cloning of lymphadenopathy-associated virus. Nature 1984;312:757-760.
23. Louwagie J, McCutchan FE, Peeters M, Brennan TP, Sanders-Buel E, Eddy GA, van der Groen G, Fransen K, Gershy-Damet GM, Deleys R, and Burke DS: Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993;7:769-780.
24. Louwagie J, Delwart EL, Mullins JI, McCutchan FE, Eddy G, and Burke DS: Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses 1994;10:561-567.
25. Sauermann U, Schneider J, Mous J, Brunckhorst U, Schedel I, Jentsch KD, and Hunsmann G: Molecular cloning and characterization of a German HIV-1 isolate. AIDS Res Hum Retroviruses 1990;6:813-823.
26. Spire B, Sire J, Zachar V, Key F, Barré-Sinoussi F, Galibert F, Hampe A, and Chermann JC: Nucleotide sequence of HIV-1-NDK a highly cytopathic strain of the human immunodeficiency virus HIV-1. Gene 1989;81:275-284.
27. Theodore T and Buckler-White AJ: Unpublished. EMBL Accession Number M22639. 1989.
28. Yoshimura FK, Dien K, Leam GH, Riddell S, and Corey L: EMBL Accession Number U29413. 1996.
29. Myers G, Korber B, Berzofsky JA, Smith RF, and Pavlakis GN: Human Retroviruses and AIDS (Database and Analysis Staff, eds.). Los Alamos National Laboratory, Los Alamos, New Mexico, 1992.
30. Fransen K, Buvé A, Nkengasong JN, Laga M, and van der Groen G: Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 1996;347:1403.
31. Loussert-Ajaka I, Descamps D, Simon F, Brun-Vezinet F, Ekwalanga M, and Saragosti S: Genetic diversity and HIV detection by polymerase chain reaction. Lancet 1995;346:912-913.
32. Coste J, Montes B, Reynes J, Peters M, Segarra C, Vendrell JP, Delaporte E, and Segondy M: Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Med Virol 1996;50:293-302.
33. Cristopherson C, Sninsky J, and Kwok S: The effects of internal primer template mismatches on RT PCR: HIV 1 model studies. Nucleic Acids Res 1997;25:654-658.